Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody.
Ni H, Cao L, Wu Z, Wang L, Zhou S, Guo X, Gao Y, Jing H, Wu M, Liu Y, Ding J, Zhang P, Zhou Y, Chen B, Xiong Y, Sun J, Prinz B, Baruah H, Geoghegan J, Yu M, Wu W, Liu J.
Ni H, et al. Among authors: liu j, liu y.
Cancer Immunol Immunother. 2022 Feb;71(2):353-363. doi: 10.1007/s00262-021-02989-2. Epub 2021 Jun 24.
Cancer Immunol Immunother. 2022.
PMID: 34165607
Free PMC article.